搜索临床试验以:干扰素β-1b/阿托伐他汀组
总计621个结果
-
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.Texas Tech University Health Sciences Center终止
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and Research完全的复发缓解型多发性硬化症
-
Shanghai Jiao Tong University School of Medicine未知
-
University Hospital, BordeauxUniversity of Bordeaux完全的
-
Sawa Ito, MDHorizon Pharma USA, Inc.完全的
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden; Merck, S.A., Portugal完全的
-
National Institute of Allergy and Infectious Diseases...主动,不招人
-
Merck KGaA, Darmstadt, GermanyMerck spol.s.r.o., Czech Republic完全的
-
EMD SeronoMerck Serono International SA完全的
-
Fundación Pública Andaluza para la Investigación...Roche Pharma AG; Andaluz Health Service; Ministerio de Economía y Competitividad, Spain完全的糖尿病,1 型
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbH完全的多发性硬化症,复发缓解
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbH完全的
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbH完全的
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbH完全的
-
Biogen完全的多发性硬化症 | 多发性硬化症,复发缓解德国
-
National Institute of Allergy and Infectious Diseases...完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty Ltd完全的
-
National Institute of Neurological Disorders and...完全的
-
EMD SeronoMerck Pte. Ltd., Singapore完全的
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的
-
PD Dr. Marcus MüllerBfARM, Bonn; DZNE, Bonn未知
-
Merck KGaA, Darmstadt, Germany完全的复发缓解型多发性硬化症德国, 爱沙尼亚, 拉脱维亚, 立陶宛, 芬兰, 奥地利, 丹麦, 荷兰, 葡萄牙, 瑞士, 挪威, 意大利
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的